• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

3,5-Difluoro-4-(pyridin-4-yl)pyridine (CAS No. 1214379-98-2): A Versatile Fluorinated Pyridine Derivative for Advanced Applications

3,5-Difluoro-4-(pyridin-4-yl)pyridine (CAS No. 1214379-98-2) is a fluorinated pyridine derivative that has gained significant attention in pharmaceutical and materials science research. This compound features a unique molecular structure combining two fluorine atoms at the 3 and 5 positions of the pyridine ring, along with a pyridin-4-yl substituent at the 4 position. The presence of multiple nitrogen atoms and fluorine substituents makes this molecule particularly interesting for drug discovery and material development.

The growing demand for fluorinated pyridine compounds in medicinal chemistry has positioned 3,5-Difluoro-4-(pyridin-4-yl)pyridine as a valuable building block. Researchers are particularly interested in how the difluoropyridine moiety can influence molecular properties such as lipophilicity, metabolic stability, and binding affinity. Recent studies have explored its potential in creating novel kinase inhibitors and other targeted therapies, addressing current challenges in cancer treatment and neurological disorders.

In materials science, 3,5-Difluoro-4-(pyridin-4-yl)pyridine serves as a precursor for developing advanced functional materials. Its rigid, planar structure and electron-deficient nature make it suitable for creating organic semiconductors and liquid crystal displays (LCDs). The compound's ability to participate in hydrogen bonding and π-π stacking interactions has opened new possibilities in supramolecular chemistry and nanotechnology applications.

The synthesis of 3,5-Difluoro-4-(pyridin-4-yl)pyridine typically involves palladium-catalyzed cross-coupling reactions between appropriately substituted pyridine derivatives. Recent advancements in synthetic methodologies have improved yields and reduced environmental impact, addressing growing concerns about sustainable chemistry practices. Researchers are actively investigating greener synthetic routes using biocatalysts or flow chemistry techniques.

Analytical characterization of 3,5-Difluoro-4-(pyridin-4-yl)pyridine reveals important physicochemical properties. The compound exhibits good thermal stability with a melting point typically above 150°C, making it suitable for various industrial processes. Spectroscopic studies (NMR, MS, IR) confirm the molecular structure and purity, which are critical for pharmaceutical applications where stringent quality standards apply.

Market trends indicate increasing demand for fluorinated heterocyclic compounds like 3,5-Difluoro-4-(pyridin-4-yl)pyridine. The global market for fluorinated pharmaceuticals is projected to grow significantly, driven by the need for more effective and selective drugs. This compound's versatility positions it well to meet these emerging needs in both academic research and industrial applications.

Recent patent filings highlight novel applications of 3,5-Difluoro-4-(pyridin-4-yl)pyridine in electronic materials and medicinal chemistry. Several pharmaceutical companies have incorporated similar structures in their drug development pipelines, particularly for treatments targeting protein kinases and G-protein-coupled receptors (GPCRs). These developments reflect the compound's potential to address current medical challenges.

Quality control and regulatory compliance are essential considerations for 3,5-Difluoro-4-(pyridin-4-yl)pyridine manufacturers. Reputable suppliers provide comprehensive analytical data, including HPLC purity certificates and detailed safety information. Proper handling procedures ensure researcher safety while maintaining compound integrity throughout storage and use.

Future research directions for 3,5-Difluoro-4-(pyridin-4-yl)pyridine include exploring its potential in agrochemicals and advanced materials. The compound's unique electronic properties make it promising for developing new pesticides with improved selectivity and environmental profiles. Additionally, its application in organic electronics continues to attract interest for next-generation display technologies.

For researchers seeking high-purity 3,5-Difluoro-4-(pyridin-4-yl)pyridine, selecting reliable suppliers with documented quality control processes is crucial. The compound's growing importance in multiple scientific disciplines ensures its continued relevance in chemical research and industrial applications for years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)